Arcadia Biosciences announced that CEO Stan Jacot has left the company and been replaced by Thomas Schaefer, effective July 5. Schaefer was previously Arcadia’s chief financial officer and will be replaced in that role by Mark Kawakami, Arcadia’s current vice president of finance.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RKDA: